{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "GBp", "esgPopulated": false, "market": "gb_market", "longName": "Oxford Cannabinoid Technologies Holdings Plc", "marketState": "CLOSED", "regularMarketPrice": 1.275, "messageBoardId": "finmb_704117554", "exchange": "LSE", "shortName": "OXFORD CANNABINOID TECHNOLOGIES", "exchangeTimezoneShortName": "BST", "exchangeTimezoneName": "Europe/London", "regularMarketChangePercent": -3.77359, "gmtOffSetMilliseconds": 3600000, "fiftyTwoWeekLowChange": 0.875, "fiftyTwoWeekLowChangePercent": 2.1875, "fiftyTwoWeekRange": "0.4 - 1.6", "fiftyTwoWeekHighChange": -0.32500005, "fiftyTwoWeekHighChangePercent": -0.20312503, "fiftyTwoWeekLow": 0.4, "fiftyTwoWeekHigh": 1.6, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.0, "firstTradeDateMilliseconds": 1621580400000, "priceHint": 4, "regularMarketChange": -0.05000007, "regularMarketTime": 1683904252, "regularMarketDayHigh": 1.375, "regularMarketDayRange": "1.25 - 1.375", "regularMarketDayLow": 1.25, "regularMarketVolume": 2054317, "regularMarketPreviousClose": 1.325, "bid": 1.25, "ask": 1.3, "fullExchangeName": "LSE", "financialCurrency": "GBP", "regularMarketOpen": 1.344, "averageDailyVolume3Month": 9534508, "averageDailyVolume10Day": 9206700, "sharesOutstanding": 960416000, "bookValue": 0.006, "fiftyDayAverage": 1.2143, "fiftyDayAverageChange": 0.06069994, "fiftyDayAverageChangePercent": 0.049987596, "twoHundredDayAverage": 0.851035, "twoHundredDayAverageChange": 0.42396498, "twoHundredDayAverageChangePercent": 0.4981757, "marketCap": 12245304, "priceToBook": 212.5, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "symbol": "OCTP.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Maddox House", "address2": "1 Maddox Street", "city": "London", "zip": "W1S 2PZ", "country": "United Kingdom", "phone": "44 20 3034 2820", "website": "https://www.oxcantech.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate is OCT461201, a selective CB2 receptor agonist in solid oral dosage form that is in pre-clinical development for use in the treatment of IBS-associated visceral pain, as well as neuropathic pain conditions, including post herpetic neuralgia. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Ms. Clarissa Ann Sowemimo-Coker", "age": 40, "title": "CEO & Director", "yearBorn": 1982, "fiscalYear": 2020, "totalPay": {"raw": 94287, "fmt": "94.29k", "longFmt": "94,287"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Indraneil  Mahapatra", "age": 42, "title": "Co-Founder & Non-Exec. Director", "yearBorn": 1980, "fiscalYear": 2020, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Eugenia  Shostak", "title": "Exec. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul William Smalley", "title": "Fin. Director & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Valentino  Parravicini", "age": 53, "title": "Chief Scientific Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robin  Bennett", "title": "Gen. Counsel & Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1609372800, "maxAge": 86400}}], "error": null}}